Infectious roseola
محل انتشار: سی و هفتمین کنگره بیماری های کودکان
سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 18
متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
PEDIATRICS37_392
تاریخ نمایه سازی: 14 شهریور 1405
چکیده مقاله:
Roseola infantum, also known as exanthem subitum or sixth disease, is a common viral infection in infants and young children, primarily caused by human herpesvirus ۶ (HHV-۶B), with HHV-۷ also implicated in some cases. This condition typically affects children between ۶ months and ۲ years of age, with peak incidence around ۷ to ۱۳ months, coinciding with the decline of maternal antibodies Clinical Presentation The disease progresses in two distinct phases. Initially, a high fever (often exceeding ۳۹.۷°C) appears abruptly and may last ۳ to ۵ days. This febrile phase can be accompanied by irritability, mild respiratory symptoms, and gastrointestinal disturbances. Notably, the fever subsides suddenly ("crisis") or gradually ("lysis"), coinciding with the onset of a characteristic rash. The rash begins as faint pink or rose-colored, nonpruritic, ۲- to ۳-mm maculopapular lesions on the trunk and spreads centrifugally to the face and extremities. It typically lasts ۱ to ۳ days and may be transient, often fading within hours. Diagnosis Diagnosis is primarily clinical, based on the sequential appearance of high fever followed by the rash. Laboratory tests, such as PCR for HHV-۶ or HHV-۷, are rarely necessary but may be considered in atypical cases or immunocompromised patients. Management Management is supportive, focusing on fever control with antipyretics like acetaminophen and ensuring adequate hydration. Febrile seizures occur in approximately ۱۰-۱۵% of cases, especially in children aged ۶ to ۱۸ months, but these are typically self-limited and do not require long-term anticonvulsant therapy. In immunocompromised children, rare complications such as encephalitis may necessitate antiviral treatment with agents like ganciclovir or foscarnet. Prognosis The prognosis is generally excellent, with most children recovering fully without complications. Reactivation of HHV-۶ can occur in immunocompromised individuals, leading to more severe manifestations. Understanding the clinical course and management of roseola is essential for pediatricians, especially in distinguishing it from other exanthematous illnesses and providing appropriate care.
نویسندگان
Maryam Zendehrouh
assistant professor of pediatric infectious disease